Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here:

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Default user image.

Daniel Engelbertsen

Assistant researcher

Default user image.

Induction of T helper 2 responses against human Apolipoprotein B100 does not affect atherosclerosis in ApoE-/- mice.


  • Daniel Engelbertsen
  • Sara Rattik
  • Anki Knutsson
  • Harry Björkbacka
  • Eva Bengtsson
  • Jan Nilsson

Summary, in English

Immune responses against LDL antigens have been found to play an important modulatory role in atherosclerosis. Immunization with homologous oxidized LDL, as well as human apolipoprotein B100 (ApoB)-derived peptides, inhibit atherosclerosis in hypercholesterolemic animal models of atherosclerosis. However, the role of antigen-specific Th2 responses in atherosclerosis remains to be fully clarified.


  • Cardiovascular Research - Immunity and Atherosclerosis
  • Vessel Wall Biology
  • EXODIAB: Excellence in Diabetes Research in Sweden
  • EpiHealth: Epidemiology for Health

Publishing year





Cardiovascular Research

Document type

Journal article


Oxford University Press


  • Cardiac and Cardiovascular Systems



Research group

  • Cardiovascular Research - Immunity and Atherosclerosis
  • Vessel Wall Biology


  • ISSN: 1755-3245